A High-Avidity T-cell Receptor Redirects Natural Killer T-cell Specificity and Outcompetes the Endogenous Invariant T-cell Receptor | Citedby Results | Cancer Immunology Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

A High-Avidity T-cell Receptor Redirects Natural Killer T-cell Specificity and Outcompetes the Endogenous Invariant T-cell Receptor

Cancer Immunol Res (2020) 8 (1): 57–69.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity

Elisa Landoni
Mark G. Woodcock
Gabriel Barragan
Gabriele Casirati
Vincenzo Cinella
Simone Stucchi
Leah M. Flick
Tracy A. Withers
Hanna Hudson
Giulia Casorati
Paolo Dellabona
Pietro Genovese
Barbara Savoldo
Leonid S. Metelitsa
Gianpietro Dotti

Nature Communications (2024) 15 (1)

invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies

Chaiyaporn Boonchalermvichian
Hao Yan
Biki Gupta
Anabel Rubin
Jeanette Baker
Robert S. Negrin

Frontiers in Transplantation (2024) 3

Primary Mouse Invariant Natural Killer T (iNKT) Cell Purification and Transduction

Gloria Delfanti
Paolo Dellabona
Giulia Casorati

BIO-PROTOCOL (2023) 13 (13)

Exploiting innate immunity for cancer immunotherapy

Ming Yi
Tianye Li
Mengke Niu
Qi Mei
Bin Zhao
Qian Chu
Zhijun Dai
Kongming Wu

Molecular Cancer (2023) 22 (1)

Natural killer T cells and other innate-like T lymphocytes as emerging platforms for allogeneic cancer cell therapy

Amy N. Courtney
Gengwen Tian
Leonid S. Metelitsa

Blood (2023) 141 (8): 869.

Adoptive Immunotherapy With Engineered iNKT Cells to Target Cancer Cells and the Suppressive Microenvironment

Gloria Delfanti
Paolo Dellabona
Giulia Casorati
Maya Fedeli

Frontiers in Medicine (2022) 9

TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells

Gloria Delfanti
Filippo Cortesi
Alessandra Perini
Gaia Antonini
Laura Azzimonti
Claudia de Lalla
Claudio Garavaglia
Mario L. Squadrito
Maya Fedeli
Michela Consonni
Silvia Sesana
Francesca Re
Haifa Shen
Paolo Dellabona
Giulia Casorati

Science Immunology (2022) 7 (74)

The effect of long-term immunosuppressive therapy on gastrointestinal symptoms after kidney transplantation

Semra Bulbuloglu
Hüseyin Gunes
Serdar Saritas

Transplant Immunology (2022) 70: 101515.

Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells

Justin T Huckaby
Elisa Landoni
Timothy M Jacobs
Barbara Savoldo
Gianpietro Dotti
Samuel K Lai

Journal for ImmunoTherapy of Cancer (2021) 9 (9): e002737.

Exploiting CD1-restricted T cells for clinical benefit

Mark A. Exley
Paolo Dellabona
Giulia Casorati

Molecular Immunology (2021) 132: 126.

Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic Signaling

Elisa Landoni
Giovanni Fucá
Jian Wang
Venkat R. Chirasani
Zhiyuan Yao
Elena Dukhovlinova
Soldano Ferrone
Barbara Savoldo
Lee K. Hong
Peishun Shou
Silvia Musio
Francesco Padelli
Gaetano Finocchiaro
Miriam Droste
Brian Kuhlman
Abdijapar Shamshiev
Serena Pellegatta
Nikolay V. Dokholyan
Gianpietro Dotti

Cancer Immunology Research (2021) 9 (4): 441.

Adoptive T cell therapy: Boosting the immune system to fight cancer

Ernesto Leon
Raghuveer Ranganathan
Barbara Savoldo

Seminars in Immunology (2020) 49: 101437.